$350.88
+17.03 (+5.10%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+112.11%
YTD
+42.11%
Open$334.76
Previous Close$333.85
Day High$353.83
Day Low$334.31
52W High$382.54
52W Low$153.20
Volume—
Avg Volume245.7K
Market Cap9.97B
P/E Ratio41.27
EPS$7.98
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$263.07
Above
SMA 200
$186.47
Above
RSI (14)
38.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
-75.3% upside
Current
$350.88
$350.88
Target
$86.77
$86.77
$54.31
$86.77 avg
$114.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 384.57M | 971.92M | 894.90M |
| Net Income | 202.43M | 120.52M | 102.54M |
| Profit Margin | 52.6% | 12.4% | 11.5% |
| EBITDA | 165.06M | 242.82M | 232.68M |
| Free Cash Flow | — | 82.52M | 69.44M |
| Rev Growth | — | +7.7% | -5.6% |
| Debt/Equity | — | 0.59 | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |